America's Blood Centers Applauds FDA's Proposed Change Eliminating Duplicative Hepatitis B Testing Requirement that Fails to Increase Safety
Summary by America's Blood Centers
1 Articles
1 Articles
America's Blood Centers Applauds FDA's Proposed Change Eliminating Duplicative Hepatitis B Testing Requirement that Fails to Increase Safety
Would reduce unnecessary regulatory burdens on blood centers while maintaining the highest standards of safety Washington, DC – America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, today applauds the Food and Drug Administration (FDA) for its draft guidance proposing the elimination of Hepatitis B Surface Antigen (HBsAg) testing for blood donat…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium